Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Nuclear Medicine and Biology|October 2, 2001
99mTc-labeling experiments on CCK(4) by a direct methodR Rossin, D Blok, R Visentin, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Sodium dithiocarb as adjuvant immunotherapy for high risk breast cancer: a randomized studyP Dufour, J M Lang, C Giron, et al.La Revue De Medecine Interne|May 1, 1991
[Hypothyroid hypertrophic myopathy following mantle irradiation for Hodgkin's disease. A case]J C Weber, P Dufour, F Maloisel, et al.Advances in Experimental Medicine and Biology|January 1, 1983
Immunomodulating effects of a short-term oral treatment with C 1821 in untreated cancer patients: a controlled studyJ M Lang, A Aleksijevic, C Giron, et al.Anti-Cancer Drugs|October 1, 1990
Cisplatin-induced anemia: a potential interference with iron metabolism at erythroid progenitors levelP Dufour, J P Bergerat, M Eber, et al.Recent Patents on Food, Nutrition & Agriculture|August 9, 2018
A Fixed Combination of Probiotics and Herbal Extracts Attenuates Intestinal Barrier Dysfunction from Inflammatory Stress in an In vitro Model Using Caco-2 CellsVeronica Cocetta, Daniela Catanzaro, Vittoria Borgonetti, et al.Cancer|February 15, 1990
Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breastF Maloisel, P Dufour, J P Bergerat, et al.Leukemia Research|January 1, 1986
Decreased membrane "fluidity" of T lymphocytes from untreated patients with Hodgkin's diseaseA Aleksijevic, G Cremel, C Mutet, et al.Cancer|April 1, 1994
Intraperitoneal mitoxantrone as consolidation treatment for patients with ovarian carcinoma in pathologic complete remissionP Dufour, J P Bergerat, J C Barats, et al.La Nouvelle Presse Medicale|October 23, 1982
[Idiopathic thrombocytopenic purpura. Treatment by intravenous transfusion of polyvalent immunoglobulins]A Faradji, J M Lang, A Boilletot, et al.Pageof 4